NP
Nishit Prakash Kadakia
About Nishit Prakash Kadakia
Data last updated:
Nishit Prakash Kadakia is a Director at Shruti Drugs Private Limited (since 1994), Director at Activz Lifesciences (I) Private Limited (since 2010) and Director at Apigran Pharma Private Limited (since 2024), and holds 5 more current directorships. The companies operate in Pharma, Recycling & Waste Management and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹47.54 Cr; the largest is Shruti Drugs Private Limited at ₹39.47 Cr (FY 2025). Earlier, Nishit Prakash Kadakia was a Director at Mars Therapeutics Private Limited (2013–2014) and Director at Accura Projects Private Limited (2007–2016) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jul 1994 | 1994 | ₹39.47 Cr (FY 2025) | Active | |
| Director | 06 Sep 2010 | 2010 | ₹8.05 Cr (FY 2024) | Active | |
| Director | 01 Apr 2024 | 2021 | ₹2.1 Lakh (FY 2025) | Active | |
| Additional Director | 01 Oct 2025 | 2021 | Active | ||
| Director | 10 Sep 2025 | 2025 | Active | ||
| Director | 19 Dec 2024 | 2024 | Active | ||
| Additional Director | 06 Feb 2019 | 2015 | Active | ||
| Director | 03 Oct 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Jul 2013 | 1993 | ₹60.85 Cr (FY 2025) | Active | |
| Director | 12 Nov 2007 | 2007 | ₹21,100 (FY 2024) | Active | |
| Director | 13 Jul 2015 | 2015 | ₹3.3 Lakh (FY 2019) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nishit Prakash Kadakia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prakash Praveen Chandra Kadakia | 01632870 | Shruti Drugs Private Limited , Sunsai Laboratories Private Limited and 1 more | Director |
| Sunil Vishram Chawda | 02369151 | Activz Lifesciences (I) Private Limited | Director |
| Kruti Nishit Kadakia | 02106582 | Apigran Pharma Private Limited , Rewas Technologies Private Limited | Director |
| Lavanya Yerram | 07088944 | Apigran Pharma Private Limited | Director |
| Swamy Sekhar Kaladi | 11001981 | Synzyme Lifesciences Private Limited | Director |
| Venkataramana Mudili | 07294845 | Biotris Biologics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nishit Prakash Kadakia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nishit Prakash Kadakia
Nishit Prakash Kadakia currently holds 8 directorships: Shruti Drugs Private Limited (Director, since 29 Jul 1994, revenue ₹39.47 Cr (FY 2025)); Activz Lifesciences (I) Private Limited (Director, since 06 Sep 2010, revenue ₹8.05 Cr (FY 2024)); Apigran Pharma Private Limited (Director, since 01 Apr 2024, revenue ₹2.1 Lakh (FY 2025)); Rewas Technologies Private Limited (Additional Director, since 01 Oct 2025); Synzyme Lifesciences Private Limited (Director, since 10 Sep 2025); and 3 more.
Nishit Prakash Kadakia was first appointed on 29 Jul 1994 as Director at Shruti Drugs Private Limited. The most recent appointment on record is 01 Oct 2025 at Rewas Technologies Private Limited.
The 3 current companies of Nishit Prakash Kadakia that report revenue have a combined latest revenue of ₹47.54 Cr: Shruti Drugs Private Limited ₹39.47 Cr (FY 2025); Activz Lifesciences (I) Private Limited ₹8.05 Cr (FY 2024); Apigran Pharma Private Limited ₹2.1 Lakh (FY 2025).
Nishit Prakash Kadakia held 3 earlier board appointments: Mars Therapeutics Private Limited (Director, 03 Jul 2013 to 30 Sep 2014); Accura Projects Private Limited (Director, 12 Nov 2007 to 19 Dec 2016); Krrum Impex Private Limited (Director, 13 Jul 2015 to 20 Aug 2015).
The current boards of Nishit Prakash Kadakia's companies include Prakash Praveen Chandra Kadakia (Shruti Drugs Private Limited), Sunil Vishram Chawda (Activz Lifesciences (I) Private Limited), Kruti Nishit Kadakia (Apigran Pharma Private Limited), Lavanya Yerram (Apigran Pharma Private Limited), Swamy Sekhar Kaladi (Synzyme Lifesciences Private Limited), Venkataramana Mudili (Biotris Biologics Private Limited).